Search





Search





Markets
/
Stocks
/
nasdaq-vrxa
/

Veraxa Biotech AG Ord Shs

VRXA

Add to Watchlist

2.390USD

+0.090+3.91%

Market hours （ET）Quotes delayed by 15 min

75.58MMarket Cap

--P/E TTM

Veraxa Biotech AG Ord Shs

2.390

+0.090+3.91%

Earnings Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Earnings Income Statement Balance Sheet Cash Flow Statement

You can check out the annual or quarterly balance sheets of Veraxa Biotech AG Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

Total equity

Cash, cash equivalents and short-term investments

--32.79K

- Cash and cash equivalents

--32.79K

Prepaid expenses

--11.54K

Total current assets

--44.33K

Non-current assets

Total non-current assets

--272.24M

Total assets

--272.28M

Liabilities

Current liabilities

-Other payables

--271.65M

Other current liabilities

--271.65M

Total current liabilities

--274.68M

Non-current liabilities

Long-term debt and lease liabilities

--0.00

Other non-current liabilities

--12.04M

Total non-current liabilities

--12.04M

Total liabilities

--286.73M

Shareholders' equity

Common equity

--890.35K

Retained earnings

---15.34M

Total equity

---14.45M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

